Referenser

  1. Folkhälsomyndigheten. Prioritera sömn och återhämtning Stockholm: Folkhälsomyndigheten; 2023 [Available from: https://dinpsykiskahalsa.se/artiklar/tips-for-att-ma-battre/skapa-bra-somnvanor/

  2. Watson NF, Badr MS, Belenky G, Bliwise DL, Buxton OM, Buysse D, et al. Recommended Amount of Sleep for a Healthy Adult: A Joint Consensus Statement of the American Academy of Sleep Medicine and Sleep Research Society. Sleep. 2015;38(6):843-4.

  3. Madrid-Valero JJ, Rubio-Aparicio M, Gregory AM, Sánchez-Meca J, Ordoñana JR. The heritability of insomnia: Systematic review and meta-analysis of twin studies. Sleep Med Rev. 2021;58:101437.

  4. Valko PO, Hunziker S, Graf K, Werth E, Baumann CR. Sleep-wake misperception. A comprehensive analysis of a large sleep lab cohort. Sleep Med. 2021;88:96-103.

  5. Riemann D, Baglioni C, Bassetti C, Bjorvatn B, Dolenc Groselj L, Ellis JG, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675-700.

  6. Coutrot A, Lazar AS, Richards M, Manley E, Wiener JM, Dalton RC, et al. Reported sleep duration reveals segmentation of the adult life-course into three phases. Nat Commun. 2022;13(1):7697.

  7. Folkhälsomyndigheten. Nationella folkhälsoenkäten ”Hälsa på lika villkor?” 2024 [Available from: https://www.folkhalsomyndigheten.se/folkhalsorapportering-statistik/om-vara-datainsamlingar/nationella-folkhalsoenkaten/

  8. Titova OE, Lindberg E, Elmståhl S, Lind L, Benedict C. Seasonal variations in sleep duration and sleep complaints: A Swedish cohort study in middle-aged and older individuals. J Sleep Res. 2022;31(1):e13453.

  9. Suzuki M, Taniguchi T, Furihata R, Yoshita K, Arai Y, Yoshiike N, et al. Seasonal changes in sleep duration and sleep problems: A prospective study in Japanese community residents. PLoS One. 2019;14(4):e0215345.

  10. Morin CM, Jarrin DC. Epidemiology of Insomnia: Prevalence, Course, Risk Factors, and Public Health Burden. Sleep Med Clin. 2022;17(2):173-91.

  11. Perlis ML, Vargas I, Ellis JG, Grandner MA, Morales KH, Gencarelli A, et al. The Natural History of Insomnia: the incidence of acute insomnia and subsequent progression to chronic insomnia or recovery in good sleeper subjects. Sleep. 2020;43(6).

  12. Ellis JG, Perlis ML, Neale LF, Espie CA, Bastien CH. The natural history of insomnia: focus on prevalence and incidence of acute insomnia. J Psychiatr Res. 2012;46(10):1278-85.

  13. Morin CM, Jarrin DC, Ivers H, Mérette C, LeBlanc M, Savard J. Incidence, Persistence, and Remission Rates of Insomnia Over 5 Years. JAMA Netw Open. 2020;3(11):e2018782.

  14. Roberts RE, Roberts CR, Chan W. Persistence and change in symptoms of insomnia among adolescents. Sleep. 2008;31(2):177-84.

  15. Kocevska D, Lysen TS, Dotinga A, Koopman-Verhoeff ME, Luijk M, Antypa N, et al. Sleep characteristics across the lifespan in 1.1 million people from the Netherlands, United Kingdom and United States: a systematic review and meta-analysis. Nat Hum Behav. 2021;5(1):113-22.

  16. Shi G, Xing L, Wu D, Bhattacharyya BJ, Jones CR, McMahon T, et al. A Rare Mutation of β(1)-Adrenergic Receptor Affects Sleep/Wake Behaviors. Neuron. 2019;103(6):1044-55.e7.

  17. Paruthi S, Brooks LJ, D'Ambrosio C, Hall WA, Kotagal S, Lloyd RM, et al. Consensus Statement of the American Academy of Sleep Medicine on the Recommended Amount of Sleep for Healthy Children: Methodology and Discussion. J Clin Sleep Med. 2016;12(11):1549-61.

  18. Staton S, Rankin PS, Harding M, Smith SS, Westwood E, LeBourgeois MK, et al. Many naps, one nap, none: A systematic review and meta-analysis of napping patterns in children 0-12 years. Sleep Med Rev. 2020;50:101247.

  19. Souabni M, Souabni MJ, Hammouda O, Romdhani M, Trabelsi K, Ammar A, et al. Benefits and risks of napping in older adults: A systematic review. Front Aging Neurosci. 2022;14:1000707.

  20. Yin J, Jin X, Shan Z, Li S, Huang H, Li P, et al. Relationship of Sleep Duration With All-Cause Mortality and Cardiovascular Events: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies. J Am Heart Assoc. 2017;6(9).

  21. Wu TT, Zou YL, Xu KD, Jiang XR, Zhou MM, Zhang SB, et al. Insomnia and multiple health outcomes: umbrella review of meta-analyses of prospective cohort studies. Public Health. 2023;215:66-74.

  22. Ge L, Guyatt G, Tian J, Pan B, Chang Y, Chen Y, et al. Insomnia and risk of mortality from all-cause, cardiovascular disease, and cancer: Systematic review and meta-analysis of prospective cohort studies. Sleep Med Rev. 2019;48:101215.

  23. Anothaisintawee T, Reutrakul S, Van Cauter E, Thakkinstian A. Sleep disturbances compared to traditional risk factors for diabetes development: Systematic review and meta-analysis. Sleep Med Rev. 2016;30:11-24.

  24. Hsieh CG, Martin JL. Short Sleep, Insomnia, and Cardiovascular Disease. Curr Sleep Med Rep. 2019;5(4):234-42.

  25. Lee SWH, Ng KY, Chin WK. The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: A systematic review and meta-analysis. Sleep Med Rev. 2017;31:91-101.

  26. Jørgensen JT, Karlsen S, Stayner L, Hansen J, Andersen ZJ. Shift work and overall and cause-specific mortality in the Danish nurse cohort. Scand J Work Environ Health. 2017;43(2):117-26.

  27. Wang F, Yeung KL, Chan WC, Kwok CC, Leung SL, Wu C, et al. A meta-analysis on dose-response relationship between night shift work and the risk of breast cancer. Ann Oncol. 2013;24(11):2724-32.

  28. Wang D, Ruan W, Chen Z, Peng Y, Li W. Shift work and risk of cardiovascular disease morbidity and mortality: A dose-response meta-analysis of cohort studies. Eur J Prev Cardiol. 2018;25(12):1293-302.

  29. Lin X, Chen W, Wei F, Ying M, Wei W, Xie X. Night-shift work increases morbidity of breast cancer and all-cause mortality: a meta-analysis of 16 prospective cohort studies. Sleep Med. 2015;16(11):1381-7.

  30. Streatfeild J, Smith J, Mansfield D, Pezzullo L, Hillman D. The social and economic cost of sleep disorders. Sleep. 2021;44(11).

  31. Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21(10):718-79.

  32. Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jönsson B, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21(9):655-79.

  33. Boubekri M, Cheung IN, Reid KJ, Wang CH, Zee PC. Impact of windows and daylight exposure on overall health and sleep quality of office workers: a case-control pilot study. J Clin Sleep Med. 2014;10(6):603-11.

  34. Didikoglu A, Mohammadian N, Johnson S, van Tongeren M, Wright P, Casson AJ, et al. Associations between light exposure and sleep timing and sleepiness while awake in a sample of UK adults in everyday life. Proc Natl Acad Sci U S A. 2023;120(42):e2301608120.

  35. Mason IC, Grimaldi D, Reid KJ, Warlick CD, Malkani RG, Abbott SM, et al. Light exposure during sleep impairs cardiometabolic function. Proc Natl Acad Sci U S A. 2022;119(12):e2113290119.

  36. Xu YX, Zhang JH, Tao FB, Sun Y. Association between exposure to light at night (LAN) and sleep problems: A systematic review and meta-analysis of observational studies. Sci Total Environ. 2023;857(Pt 1):159303.

  37. Bademli K, Lok N, Canbaz M, Lok S. Effects of Physical Activity Program on cognitive function and sleep quality in elderly with mild cognitive impairment: A randomized controlled trial. Perspect Psychiatr Care. 2019;55(3):401-8.

  38. Stutz J, Eiholzer R, Spengler CM. Effects of Evening Exercise on Sleep in Healthy Participants: A Systematic Review and Meta-Analysis. Sports Med. 2019;49(2):269-87.

  39. Amiri S, Hasani J, Satkin M. Effect of exercise training on improving sleep disturbances: a systematic review and meta-analysis of randomized control trials. Sleep Med. 2021;84:205-18.

  40. Shahdadian F, Boozari B, Saneei P. Association between short sleep duration and intake of sugar and sugar-sweetened beverages: A systematic review and meta-analysis of observational studies. Sleep Health. 2023;9(2):159-76.

  41. Godos J, Grosso G, Castellano S, Galvano F, Caraci F, Ferri R. Association between diet and sleep quality: A systematic review. Sleep Med Rev. 2021;57:101430.

  42. Leach MJ, Page AT. Herbal medicine for insomnia: A systematic review and meta-analysis. Sleep Med Rev. 2015;24:1-12.

  43. Eriksson C, Bodin T, Selander J. Burden of disease from road traffic and railway noise - a quantification of healthy life years lost in Sweden. Scand J Work Environ Health. 2017;43(6):519-25.

  44. Obradovich N, Migliorini R, Mednick SC, Fowler JH. Nighttime temperature and human sleep loss in a changing climate. Sci Adv. 2017;3(5):e1601555.

  45. Minor K, Bjerre-Nielsen A, Jonasdottir SS, Lehmann S, Obradovich N. Rising temperatures erode human sleep globally. One Earth. 2022;5(5):534-49.

  46. Baniassadi A, Manor B, Yu W, Travison T, Lipsitz L. Nighttime ambient temperature and sleep in community-dwelling older adults. Sci Total Environ. 2023;899:165623.

  47. Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep. 2004;27(7):1255-73.

  48. Salo P, Vahtera J, Ferrie JE, Akbaraly T, Goldberg M, Zins M, et al. Trajectories of sleep complaints from early midlife to old age: longitudinal modeling study. Sleep. 2012;35(11):1559-68.

  49. Bubenik GA, Konturek SJ. Melatonin and aging: prospects for human treatment. J Physiol Pharmacol. 2011;62(1):13-9.

  50. Zhao W, Van Someren EJW, Li C, Chen X, Gui W, Tian Y, et al. EEG spectral analysis in insomnia disorder: A systematic review and meta-analysis. Sleep Med Rev. 2021;59:101457.

  51. Konofal E, Lecendreux M, Cortese S. Sleep and ADHD. Sleep Med. 2010;11(7):652-8.

  52. Westergren S. Sömnstörning: Internetmedicin; 2024 [Available from: https://www.internetmedicin.se/psykiatri/somnstorningar

  53. Baglioni C, Nanovska S, Regen W, Spiegelhalder K, Feige B, Nissen C, et al. Sleep and mental disorders: A meta-analysis of polysomnographic research. Psychol Bull. 2016;142(9):969-90.

  54. Chellappa SL, Aeschbach D. Sleep and anxiety: From mechanisms to interventions. Sleep Med Rev. 2022;61:101583.

  55. Riemann D, Krone LB, Wulff K, Nissen C. Sleep, insomnia, and depression. Neuropsychopharmacology. 2020;45(1):74-89.

  56. Söderpalm B, Ericson M. Alcohol and the dopamine system. Int Rev Neurobiol. 2024;175:21-73.

  57. Koob GF, Colrain IM. Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework. Neuropsychopharmacology. 2020;45(1):141-65.

  58. Gardiner C, Weakley J, Burke LM, Roach GD, Sargent C, Maniar N, et al. The effect of alcohol on subsequent sleep in healthy adults: A systematic review and meta-analysis. Sleep Med Rev. 2025;80:102030.

  59. Pietilä J, Helander E, Korhonen I, Myllymäki T, Kujala UM, Lindholm H. Acute Effect of Alcohol Intake on Cardiovascular Autonomic Regulation During the First Hours of Sleep in a Large Real-World Sample of Finnish Employees: Observational Study. JMIR Ment Health. 2018;5(1):e23.

  60. Fatemi SH, Reutiman TJ, Folsom TD, Thuras PD. GABA(A) receptor downregulation in brains of subjects with autism. J Autism Dev Disord. 2009;39(2):223-30.

  61. Johnson KP, Zarrinnegar P. Autism Spectrum Disorder and Sleep. Child Adolesc Psychiatr Clin N Am. 2021;30(1):195-208.

  62. Reynolds AM, Malow BA. Sleep and autism spectrum disorders. Pediatr Clin North Am. 2011;58(3):685-98.

  63. Rossignol DA, Frye RE. Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol. 2011;53(9):783-92.

  64. Emet M, Ozcan H, Ozel L, Yayla M, Halici Z, Hacimuftuoglu A. A Review of Melatonin, Its Receptors and Drugs. Eurasian J Med. 2016;48(2):135-41.

  65. Lane SJ, Leão MA, Spielmann V. Sleep, Sensory Integration/Processing, and Autism: A Scoping Review. Front Psychol. 2022;13:877527.

  66. Ballester P, Richdale AL, Baker EK, Peiró AM. Sleep in autism: A biomolecular approach to aetiology and treatment. Sleep Med Rev. 2020;54:101357.

  67. Singh K, Zimmerman AW. Sleep in Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder. Semin Pediatr Neurol. 2015;22(2):113-25.

  68. Baird AL, Coogan AN, Siddiqui A, Donev RM, Thome J. Adult attention-deficit hyperactivity disorder is associated with alterations in circadian rhythms at the behavioural, endocrine and molecular levels. Mol Psychiatry. 2012;17(10):988-95.

  69. Edden RA, Crocetti D, Zhu H, Gilbert DL, Mostofsky SH. Reduced GABA concentration in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2012;69(7):750-3.

  70. Elia J, Glessner JT, Wang K, Takahashi N, Shtir CJ, Hadley D, et al. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet. 2011;44(1):78-84.

  71. Korman M, Palm D, Uzoni A, Faltraco F, Tucha O, Thome J, et al. ADHD 24/7: Circadian clock genes, chronotherapy and sleep/wake cycle insufficiencies in ADHD. World J Biol Psychiatry. 2020;21(3):156-71.

  72. Langberg JM, Breaux RP, Cusick CN, Green CD, Smith ZR, Molitor SJ, et al. Intraindividual variability of sleep/wake patterns in adolescents with and without attention-deficit/hyperactivity disorder. J Child Psychol Psychiatry. 2019;60(11):1219-29.

  73. Cortese S, Hill CM. Sleep and ADHD: Adding pieces to the puzzle. Sleep Med. 2023;103:144-5.

  74. Cortese S. Sleep and ADHD: what we know and what we do not know. Sleep Med. 2015;16(1):5-6.

  75. Walters AS, Silvestri R, Zucconi M, Chandrashekariah R, Konofal E. Review of the possible relationship and hypothetical links between attention deficit hyperactivity disorder (ADHD) and the simple sleep related movement disorders, parasomnias, hypersomnias, and circadian rhythm disorders. J Clin Sleep Med. 2008;4(6):591-600.

  76. Gardiner C, Weakley J, Burke LM, Roach GD, Sargent C, Maniar N, et al. The effect of caffeine on subsequent sleep: A systematic review and meta-analysis. Sleep Med Rev. 2023;69:101764.

  77. Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev. 1999;51(1):83-133.

  78. Snitselaar MA, Smits MG, van der Heijden KB, Spijker J. Sleep and Circadian Rhythmicity in Adult ADHD and the Effect of Stimulants. J Atten Disord. 2017;21(1):14-26.

  79. Ryu H, Ju S, Lee HE, Cho SS. Commuting time, working time, and their link to insomnia symptoms among Korean employees: A cross-sectional study. Sleep Health. 2024;10(4):434-40.

  80. Petrov ME, Weng J, Reid KJ, Wang R, Ramos AR, Wallace DM, et al. Commuting and Sleep: Results From the Hispanic Community Health Study/Study of Latinos Sueño Ancillary Study. Am J Prev Med. 2018;54(3):e49-e57.

  81. Zhu L, Zee PC. Circadian rhythm sleep disorders. Neurol Clin. 2012;30(4):1167-91.

  82. Sun Y, Laksono I, Selvanathan J, Saripella A, Nagappa M, Pham C, et al. Prevalence of sleep disturbances in patients with chronic non-cancer pain: A systematic review and meta-analysis. Sleep Med Rev. 2021;57:101467.

  83. Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8(2):130-40.

  84. Merikanto I, Dauvilliers Y, Chung F, Wing YK, De Gennaro L, Holzinger B, et al. Sleep symptoms are essential features of long-COVID - Comparing healthy controls with COVID-19 cases of different severity in the international COVID sleep study (ICOSS-II). J Sleep Res. 2023;32(1):e13754.

  85. Gagnon C, Bélanger L, Ivers H, Morin CM. Validation of the Insomnia Severity Index in primary care. J Am Board Fam Med. 2013;26(6):701-10.

  86. Kathol RG, Arnedt JT. Cognitive Behavioral Therapy for Chronic Insomnia: Confronting the Challenges to Implementation. Ann Intern Med. 2016;165(2):149-50.

  87. Feige B, Al-Shajlawi A, Nissen C, Voderholzer U, Hornyak M, Spiegelhalder K, et al. Does REM sleep contribute to subjective wake time in primary insomnia? A comparison of polysomnographic and subjective sleep in 100 patients. J Sleep Res. 2008;17(2):180-90.

  88. Caddick ZA, Gregory K, Arsintescu L, Flynn-Evans EE. A review of the environmental parameters necessary for an optimal sleep environment. Building and Environment. 2018;132:11-20.

  89. He M, Ru T, Li S, Li Y, Zhou G. Shine light on sleep: Morning bright light improves nocturnal sleep and next morning alertness among college students. J Sleep Res. 2023;32(2):e13724.

  90. Brown TM, Brainard GC, Cajochen C, Czeisler CA, Hanifin JP, Lockley SW, et al. Recommendations for daytime, evening, and nighttime indoor light exposure to best support physiology, sleep, and wakefulness in healthy adults. PLoS Biol. 2022;20(3):e3001571.

  91. Verreault MD, Granger É, Neveu X, Delage JP, Bastien CH, Vallières A. The effectiveness of stimulus control in cognitive behavioural therapy for insomnia in adults: A systematic review and network meta-analysis. J Sleep Res. 2023:e14008.

  92. Jansson-Fröjmark M, Nordenstam L, Alfonsson S, Bohman B, Rozental A, Norell-Clarke A. Stimulus control for insomnia: A systematic review and meta-analysis. J Sleep Res. 2024;33(1):e14002.

  93. Steinmetz L, Simon L, Feige B, Riemann D, Johann AF, Ell J, et al. Network meta-analysis examining efficacy of components of cognitive behavioural therapy for insomnia. Clin Psychol Rev. 2024;114:102507.

  94. Montserrat Sánchez-Ortuño M, Edinger JD. A penny for your thoughts: patterns of sleep-related beliefs, insomnia symptoms and treatment outcome. Behav Res Ther. 2010;48(2):125-33.

  95. Trauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D. Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis. Ann Intern Med. 2015;163(3):191-204.

  96. Buysse DJ, Rush AJ, Reynolds CF, III. Clinical Management of Insomnia Disorder. JAMA. 2017;318(20):1973-4.

  97. Alimoradi Z, Jafari E, Broström A, Ohayon MM, Lin CY, Griffiths MD, et al. Effects of cognitive behavioral therapy for insomnia (CBT-I) on quality of life: A systematic review and meta-analysis. Sleep Med Rev. 2022;64:101646.

  98. Sivertsen B, Omvik S, Pallesen S, Bjorvatn B, Havik OE, Kvale G, et al. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. Jama. 2006;295(24):2851-8.

  99. Kyle SD, Siriwardena AN, Espie CA, Yang Y, Petrou S, Ogburn E, et al. Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial. Lancet. 2023;402(10406):975-87.

  100. Ritterband LM, Thorndike FP, Ingersoll KS, Lord HR, Gonder-Frederick L, Frederick C, et al. Effect of a Web-Based Cognitive Behavior Therapy for Insomnia Intervention With 1-Year Follow-up: A Randomized Clinical Trial. JAMA Psychiatry. 2017;74(1):68-75.

  101. Ho FY, Chung KF, Yeung WF, Ng TH, Kwan KS, Yung KP, et al. Self-help cognitive-behavioral therapy for insomnia: a meta-analysis of randomized controlled trials. Sleep Med Rev. 2015;19:17-28.

  102. Vedaa Ø, Hagatun S, Kallestad H, Pallesen S, Smith ORF, Thorndike FP, et al. Long-Term Effects of an Unguided Online Cognitive Behavioral Therapy for Chronic Insomnia. J Clin Sleep Med. 2019;15(1):101-10.

  103. Irwin MR, Carrillo C, Sadeghi N, Bjurstrom MF, Breen EC, Olmstead R. Prevention of Incident and Recurrent Major Depression in Older Adults With Insomnia: A Randomized Clinical Trial. JAMA Psychiatry. 2022;79(1):33-41.

  104. Enomoto M, Kitamura S, Tachimori H, Takeshima M, Mishima K. Long-term use of hypnotics: Analysis of trends and risk factors. Gen Hosp Psychiatry. 2020;62:49-55.

  105. van der Zweerde T, Bisdounis L, Kyle SD, Lancee J, van Straten A. Cognitive behavioral therapy for insomnia: A meta-analysis of long-term effects in controlled studies. Sleep Med Rev. 2019;48:101208.

  106. Hetta J, Axelsson S, Eckerlund I. Behandling av sömnbesvär hos vuxna: Läkartidningen; 2010 [Available from: https://lakartidningen.se/klinik-och-vetenskap-1/2010/11/behandling-av-somnbesvar-hos-vuxna/

  107. Palagini L, Manni R, Aguglia E, Amore M, Brugnoli R, Bioulac S, et al. International Expert Opinions and Recommendations on the Use of Melatonin in the Treatment of Insomnia and Circadian Sleep Disturbances in Adult Neuropsychiatric Disorders. Front Psychiatry. 2021;12:688890.

  108. Amaral FGD, Cipolla-Neto J. A brief review about melatonin, a pineal hormone. Arch Endocrinol Metab. 2018;62(4):472-9.

  109. Waldhauser F, Lieberman HR, Lynch HJ, Waldhauser M, Herkner K, Frisch H, et al. A pharmacological dose of melatonin increases PRL levels in males without altering those of GH, LH, FSH, TSH, testosterone or cortisol. Neuroendocrinology. 1987;46(2):125-30.

  110. Venaki E, Koukkou E, Ilias I. Melatonin's actions are not limited to sleep. World J Exp Med. 2023;13(2):4-6.

  111. Carranza-Lira S, García López F. Melatonin and climactery. Med Sci Monit. 2000;6(6):1209-12.

  112. Norwegian Institute of Public Health, Statistics WCCfD. ATC/DDD Index 2024 Oslo: Norwegian Institute of Public Health; 2024 [Available from: https://atcddd.fhi.no/atc_ddd_index/

  113. Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013;8(5):e63773.

  114. Wade AG, Ford I, Crawford G, McConnachie A, Nir T, Laudon M, et al. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety. BMC Med. 2010;8:51.

  115. Nogueira HA, de Castro CT, da Silva DCG, Pereira M. Melatonin for sleep disorders in people with autism: Systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2023;123:110695.

  116. RELIS. Melatonin och långtidseffekter? : Produsentuavhengig legemiddelinformasjon for helsepersonell; 2018 [Available from: https://relis.no/sporsmal_og_svar/?id=13%2D798

  117. Green B. Prazosin in the treatment of PTSD. J Psychiatr Pract. 2014;20(4):253-9.

  118. Lundgren C. FAS UT 2024: Att utvärdera, ifrågasätta och skonsamt avsluta läkemedelsbehandling. 4 ed: Studentlitteratur; 2023. 519 p.

  119. Becker SP. ADHD and sleep: recent advances and future directions. Curr Opin Psychol. 2020;34:50-6.

  120. Knez R, Stevanovic D, Fernell E, Gillberg C. Orexin/Hypocretin System Dysfunction in ESSENCE (Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations). Neuropsychiatr Dis Treat. 2022;18:2683-702.

  121. Ribbe M, Mellén A. Daridorexant vid sömnstörning: Regionernas samverkansmodell för läkemedel; 2021 [Available from: https://samverkanlakemedel.se/download/18.25cdd0fd18e65a1a5d02a2b9/1640083717265/Daridorexant-vid-s%C3%B6mnst%C3%B6rning-tidig-bedomningsrapport-211206.pdf

  122. Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7(8):687-98.

  123. Jonassen TM, Bjorvatn B, Saxvig IW, Eagan TM, Lehmann S. Clinical information predicting severe obstructive sleep apnea: A cross-sectional study of patients waiting for sleep diagnostics. Respir Med. 2022;197:106860.

  124. Braley TJ, Dunietz GL, Chervin RD, Lisabeth LD, Skolarus LE, Burke JF. Recognition and Diagnosis of Obstructive Sleep Apnea in Older Americans. J Am Geriatr Soc. 2018;66(7):1296-302.

  125. Seravalle G, Grassi G. Sleep Apnea and Hypertension. High Blood Press Cardiovasc Prev. 2022;29(1):23-31.

  126. McDermott M, Brown DL. Sleep apnea and stroke. Curr Opin Neurol. 2020;33(1):4-9.

  127. Vanek J, Prasko J, Genzor S, Ociskova M, Kantor K, Holubova M, et al. Obstructive sleep apnea, depression and cognitive impairment. Sleep Med. 2020;72:50-8.

  128. Grote L, Hedner J. Sömnhandboken: en klinisk guide med fallbeskrivningar: Inertia i samarbete med Affecta; 2012.

  129. Ruoff C, Rye D. The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality. Curr Med Res Opin. 2016;32(10):1611-22.

  130. Ohayon MM, Priest RG, Zulley J, Smirne S, Paiva T. Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology. 2002;58(12):1826-33.

  131. Barateau L, Lopez R, Dauvilliers Y. Clinical neurophysiology of CNS hypersomnias. Handb Clin Neurol. 2019;161:353-67.

  132. Mignot E. Genetic and familial aspects of narcolepsy. Neurology. 1998;50(2 Suppl 1):S16-22.

  133. Sarkanen TO, Alakuijala APE, Dauvilliers YA, Partinen MM. Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis. Sleep Med Rev. 2018;38:177-86.

  134. Billiard M, Bassetti C, Dauvilliers Y, Dolenc-Groselj L, Lammers GJ, Mayer G, et al. EFNS guidelines on management of narcolepsy. Eur J Neurol. 2006;13(10):1035-48.

  135. NPO Nervsystemets sjukdomar. Riktlinje för behandling av narkolepsi hos barn och vuxna: Sveriges regioner i samverkan; 2022 [Available from: https://kunskapsstyrningvard.se/kunskapsstyrningvard/kunskapsstod/publiceradekunskapsstod/nervsystemetssjukdomar/narkolepsivardriktlinje.74083.html

  136. Bassetti CLA, Kallweit U, Vignatelli L, Plazzi G, Lecendreux M, Baldin E, et al. European guideline and expert statements on the management of narcolepsy in adults and children. J Sleep Res. 2021;30(6):e13387.

  137. Maski K, Mignot E, Plazzi G, Dauvilliers Y. Disrupted nighttime sleep and sleep instability in narcolepsy. J Clin Sleep Med. 2022;18(1):289-304.

  138. Jin L, Shi L, Zhang Y, Chen BB, Wang XL, Liu YH. Antidepressants for the treatment of narcolepsy: A prospective study of 148 patients in northern China. J Clin Neurosci. 2019;63:27-31.

  139. Ohayon MM, Dauvilliers Y, Reynolds CF, 3rd. Operational definitions and algorithms for excessive sleepiness in the general population: implications for DSM-5 nosology. Arch Gen Psychiatry. 2012;69(1):71-9.

  140. Boulanger T, Pigeon P, Crawford S. Diagnostic challenges and burden of idiopathic hypersomnia: a systematic literature review. Sleep Adv. 2024;5(1):zpae059.

  141. Arnulf I, Thomas R, Roy A, Dauvilliers Y. Update on the treatment of idiopathic hypersomnia: Progress, challenges, and expert opinion. Sleep Med Rev. 2023;69:101766.

  142. Neikrug AB, Crawford MR, Ong JC. Behavioral Sleep Medicine Services for Hypersomnia Disorders: A Survey Study. Behav Sleep Med. 2017;15(2):158-71.

  143. Nigam M, Hippolyte A, Dodet P, Gales A, Maranci JB, Al-Youssef S, et al. Sleeping through a pandemic: impact of COVID-19-related restrictions on narcolepsy and idiopathic hypersomnia. J Clin Sleep Med. 2022;18(1):255-63.

  144. Inoue Y, Tabata T, Tsukimori N. Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Medicine. 2021;80:315-21.

  145. Mayer G, Benes H, Young P, Bitterlich M, Rodenbeck A. Modafinil in the treatment of idiopathic hypersomnia without long sleep time--a randomized, double-blind, placebo-controlled study. J Sleep Res. 2015;24(1):74-81.

  146. Dauvilliers Y, Arnulf I, Foldvary-Schaefer N, Morse AM, Šonka K, Thorpy MJ, et al. Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study. Lancet Neurol. 2022;21(1):53-65.

  147. AlShareef SM, Smith RM, BaHammam AS. Kleine-Levin syndrome: clues to aetiology. Sleep Breath. 2018;22(3):613-23.

  148. Castelnovo A, Loddo G, Provini F, Miano S, Manconi M. Mental Activity During Episodes of Sleepwalking, Night Terrors or Confusional Arousals: Differences Between Children and Adults. Nat Sci Sleep. 2021;13:829-40.

  149. Cataldi J, Stephan AM, Haba-Rubio J, Siclari F. Shared EEG correlates between non-REM parasomnia experiences and dreams. Nat Commun. 2024;15(1):3906.

  150. Petit D, Pennestri MH, Paquet J, Desautels A, Zadra A, Vitaro F, et al. Childhood Sleepwalking and Sleep Terrors: A Longitudinal Study of Prevalence and Familial Aggregation. JAMA Pediatr. 2015;169(7):653-8.

  151. Laberge L, Tremblay RE, Vitaro F, Montplaisir J. Development of parasomnias from childhood to early adolescence. Pediatrics. 2000;106(1 Pt 1):67-74.

  152. Hublin C, Kaprio J, Partinen M, Heikkilä K, Koskenvuo M. Prevalence and genetics of sleepwalking: a population-based twin study. Neurology. 1997;48(1):177-81.

  153. Idir Y, Oudiette D, Arnulf I. Sleepwalking, sleep terrors, sexsomnia and other disorders of arousal: the old and the new. J Sleep Res. 2022;31(4):e13596.

  154. Zergham AS, Chauhan Z. Somnambulism. Treasure Island (FL): StatPearls; 2023.

  155. Arnulf I. Sleepwalking. Curr Biol. 2018;28(22):R1288-r9.

  156. Harris M, Grunstein RR. Treatments for somnambulism in adults: assessing the evidence. Sleep Med Rev. 2009;13(4):295-7.

  157. Attarian H. Treatment options for parasomnias. Neurol Clin. 2010;28(4):1089-106.

  158. Sharpless BA, Kliková M. Clinical features of isolated sleep paralysis. Sleep Med. 2019;58:102-6.

  159. Denis D, French CC, Gregory AM. A systematic review of variables associated with sleep paralysis. Sleep Med Rev. 2018;38:141-57.

  160. Sharpless BA, Barber JP. Lifetime prevalence rates of sleep paralysis: a systematic review. Sleep Med Rev. 2011;15(5):311-5.

  161. Allada R, Bass J. Circadian Mechanisms in Medicine. N Engl J Med. 2021;384(6):550-61.

  162. Cedernaes J, Ramsey KM, Bass J. The Role of Circadian Biology in Health and Disease. In: Longo D, Fauci A, Kasper D, Hauser S, Jameson JL, Loscalzo J, et al., editors. Harrison's Principles of Internal Medicine, 22nd Edition. New York, NY: McGraw Hill; 2026.

  163. Sweileh WM. Analysis and mapping of global research publications on shift work (2012-2021). J Occup Med Toxicol. 2022;17(1):22.

  164. Hai Y, Xue Y, Wang YH. Does Long-Term Shift Work Increase the Risk of Dementia? A Systematic Review and Meta-Analysis. Am J Alzheimers Dis Other Demen. 2022;37:15333175221141535.

  165. Hedström AK, Åkerstedt T, Hillert J, Olsson T, Alfredsson L. Shift work at young age is associated with increased risk for multiple sclerosis. Ann Neurol. 2011;70(5):733-41.

  166. Gao Y, Fu X, Hu H, Li T, Yuan L, Zhang J, et al. Impact of shift work on dementia: a systematic review and dose-response meta-analysis. Public Health. 2023;223:80-6.

  167. Xu M, Yin X, Gong Y. Lifestyle Factors in the Association of Shift Work and Depression and Anxiety. JAMA Netw Open. 2023;6(8):e2328798.

  168. Boini S, Bourgkard E, Ferrières J, Esquirol Y. What do we know about the effect of night-shift work on cardiovascular risk factors? An umbrella review. Front Public Health. 2022;10:1034195.

  169. Su F, Huang D, Wang H, Yang Z. Associations of shift work and night work with risk of all-cause, cardiovascular and cancer mortality: a meta-analysis of cohort studies. Sleep Med. 2021;86:90-8.

  170. Roenneberg T, Kuehnle T, Juda M, Kantermann T, Allebrandt K, Gordijn M, et al. Epidemiology of the human circadian clock. Sleep Med Rev. 2007;11(6):429-38.

  171. Zhang MM, Ma Y, Du LT, Wang K, Li Z, Zhu W, et al. Sleep disorders and non-sleep circadian disorders predict depression: A systematic review and meta-analysis of longitudinal studies. Neurosci Biobehav Rev. 2022;134:104532.

  172. Ho FY, Poon CY, Wong VW, Chan KW, Law KW, Yeung WF, et al. Actigraphic monitoring of sleep and circadian rest-activity rhythm in individuals with major depressive disorder or depressive symptoms: A meta-analysis. J Affect Disord. 2024;361:224-44.

  173. Seleem MA, Merranko JA, Goldstein TR, Goldstein BI, Axelson DA, Brent DA, et al. The longitudinal course of sleep timing and circadian preferences in adults with bipolar disorder. Bipolar Disord. 2015;17(4):392-402.

  174. Takaesu Y, Inoue Y, Murakoshi A, Komada Y, Otsuka A, Futenma K, et al. Prevalence of Circadian Rhythm Sleep-Wake Disorders and Associated Factors in Euthymic Patients with Bipolar Disorder. PLoS One. 2016;11(7):e0159578.

  175. Cohrs S. Sleep disturbances in patients with schizophrenia : impact and effect of antipsychotics. CNS Drugs. 2008;22(11):939-62.

  176. Wulff K, Dijk DJ, Middleton B, Foster RG, Joyce EM. Sleep and circadian rhythm disruption in schizophrenia. Br J Psychiatry. 2012;200(4):308-16.

  177. Martin J, Jeste DV, Caliguiri MP, Patterson T, Heaton R, Ancoli-Israel S. Actigraphic estimates of circadian rhythms and sleep/wake in older schizophrenia patients. Schizophr Res. 2001;47(1):77-86.

  178. Horne JA, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976;4(2):97-110.

  179. Wright KP, Jr., McHill AW, Birks BR, Griffin BR, Rusterholz T, Chinoy ED. Entrainment of the human circadian clock to the natural light-dark cycle. Curr Biol. 2013;23(16):1554-8.

  180. Zerbini G, Winnebeck EC, Merrow M. Weekly, seasonal, and chronotype-dependent variation of dim-light melatonin onset. J Pineal Res. 2021;70(3):e12723.

  181. Dunster GP, Hua I, Grahe A, Fleischer JG, Panda S, Wright KP, Jr., et al. Daytime light exposure is a strong predictor of seasonal variation in sleep and circadian timing of university students. J Pineal Res. 2023;74(2):e12843.

  182. Stothard ER, McHill AW, Depner CM, Birks BR, Moehlman TM, Ritchie HK, et al. Circadian Entrainment to the Natural Light-Dark Cycle across Seasons and the Weekend. Curr Biol. 2017;27(4):508-13.

  183. Keijzer H, Smits MG, Duffy JF, Curfs LM. Why the dim light melatonin onset (DLMO) should be measured before treatment of patients with circadian rhythm sleep disorders. Sleep Med Rev. 2014;18(4):333-9.

  184. Leproult R, Colecchia EF, L'Hermite-Balériaux M, Van Cauter E. Transition from dim to bright light in the morning induces an immediate elevation of cortisol levels. J Clin Endocrinol Metab. 2001;86(1):151-7.

  185. Sansom K, Reynolds A, McVeigh J, Mazzotti DR, Dhaliwal SS, Maddison K, et al. Estimating sleep duration: performance of open-source processing of actigraphy compared to in-laboratory polysomnography in the community. Sleep Adv. 2023;4(1):zpad028.

  186. Auger RR, Burgess HJ, Emens JS, Deriy LV, Thomas SM, Sharkey KM. Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2015;11(10):1199-236.

  187. Morgenthaler TI, Lee-Chiong T, Alessi C, Friedman L, Aurora RN, Boehlecke B, et al. Practice Parameters for the Clinical Evaluation and Treatment of Circadian Rhythm Sleep Disorders. Sleep. 2007;30(11):1445-59.

  188. Patke A, Murphy PJ, Onat OE, Krieger AC, Özçelik T, Campbell SS, et al. Mutation of the Human Circadian Clock Gene CRY1 in Familial Delayed Sleep Phase Disorder. Cell. 2017;169(2):203-15.e13.

  189. Bjorvatn B, Pallesen S. A practical approach to circadian rhythm sleep disorders. Sleep Med Rev. 2009;13(1):47-60.

  190. Curtis BJ, Ashbrook LH, Young T, Finn LA, Fu YH, Ptáček LJ, et al. Extreme morning chronotypes are often familial and not exceedingly rare: the estimated prevalence of advanced sleep phase, familial advanced sleep phase, and advanced sleep-wake phase disorder in a sleep clinic population. Sleep. 2019;42(10).

  191. Flynn-Evans EE, Tabandeh H, Skene DJ, Lockley SW. Circadian Rhythm Disorders and Melatonin Production in 127 Blind Women with and without Light Perception. J Biol Rhythms. 2014;29(3):215-24.

  192. Sack RL, Brandes RW, Kendall AR, Lewy AJ. Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med. 2000;343(15):1070-7.

  193. Emens JS, Eastman CI. Diagnosis and Treatment of Non-24-h Sleep-Wake Disorder in the Blind. Drugs. 2017;77(6):637-50.

  194. Wright KP, Jr., Bogan RK, Wyatt JK. Shift work and the assessment and management of shift work disorder (SWD). Sleep Med Rev. 2013;17(1):41-54.

  195. Pallesen S, Bjorvatn B, Waage S, Harris A, Sagoe D. Prevalence of Shift Work Disorder: A Systematic Review and Meta-Analysis. Front Psychol. 2021;12:638252.

  196. Wickwire EM, Geiger-Brown J, Scharf SM, Drake CL. Shift Work and Shift Work Sleep Disorder: Clinical and Organizational Perspectives. Chest. 2017;151(5):1156-72.

  197. Zee PC, Goldstein CA. Treatment of shift work disorder and jet lag. Curr Treat Options Neurol. 2010;12(5):396-411.

  198. Eastman CI, Gazda CJ, Burgess HJ, Crowley SJ, Fogg LF. Advancing circadian rhythms before eastward flight: a strategy to prevent or reduce jet lag. Sleep. 2005;28(1):33-44.

  199. Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev. 2002(2):Cd001520.

  200. Sack RL. Clinical practice. Jet lag. N Engl J Med. 2010;362(5):440-7.

  201. Wittmann M, Dinich J, Merrow M, Roenneberg T. Social jetlag: misalignment of biological and social time. Chronobiol Int. 2006;23(1-2):497-509.

  202. Díaz-Morales JF, Escribano C. Social jetlag, academic achievement and cognitive performance: Understanding gender/sex differences. Chronobiol Int. 2015;32(6):822-31.

  203. Roenneberg T, Allebrandt KV, Merrow M, Vetter C. Social jetlag and obesity. Curr Biol. 2012;22(10):939-43.

  204. Sieminski M, Partinen M. Nocturnal systolic blood pressure is increased in restless legs syndrome. Sleep Breath. 2016;20(3):1013-9.

  205. Romero-Peralta S, Cano-Pumarega I, García-Borreguero D. Emerging Concepts of the Pathophysiology and Adverse Outcomes of Restless Legs Syndrome. Chest. 2020;158(3):1218-29.

  206. Innes KE, Selfe TK, Agarwal P. Prevalence of restless legs syndrome in North American and Western European populations: a systematic review. Sleep Med. 2011;12(7):623-34.

  207. Ekbom K, Leissner, L., Olsson J-E., Widner H.,. Restless legs – vanligt sjukdomstillstånd som ofta missas. Läkartidningen. 2006;103(4):207-11.

  208. Kolla BP, Mansukhani MP, Bostwick JM. The influence of antidepressants on restless legs syndrome and periodic limb movements: A systematic review. Sleep Med Rev. 2018;38:131-40.

  209. Qadri SN, Jamil S, Zahid S, Asghar T, Gillani SM, Qasim SA, et al. Clinical efficacy and safety of IV ferric carboxymaltose in restless legs syndrome: A meta-analysis of 537 patients. Sleep Med. 2024;124:244-53

  210. Trotti LM, Becker LA. Iron for the treatment of restless legs syndrome. Cochrane Database Syst Rev. 2019;1(1):Cd007834.

  211. Winkelman JW, Berkowski JA, DelRosso LM, Koo BB, Scharf MT, Sharon D, et al. Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2025;21(1):137-52.

  212. Earley CJ, Connor JR, Beard JL, Clardy SL, Allen RP. Ferritin levels in the cerebrospinal fluid and restless legs syndrome: effects of different clinical phenotypes. Sleep. 2005;28(9):1069-75.

  213. Garcia-Borreguero D, Silber MH, Winkelman JW, Högl B, Bainbridge J, Buchfuhrer M, et al. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Med. 2016;21:1-11.

  214. Janusinfo. Behandling av restless legs hos vuxna Stockholm: Region Stockholm; 2024 [Available from: https://janusinfo.se/behandling/expertgruppsutlatanden/nervsystemetssjukdomar/nervsystemetssjukdomar/behandlingavrestlesslegshosvuxna.5.3daa1b3d160c00a26d237a9.html

  215. Carlos K, Prado GF, Teixeira CD, Conti C, de Oliveira MM, Prado LB, et al. Benzodiazepines for restless legs syndrome. Cochrane Database Syst Rev. 2017;3(3):Cd006939.

  216. Walters AS, Spruyt K, Ba DM, Gao X. A Historical Overview of the Role of Benzodiazepines including Clonazepam in the Treatment of Adult Restless Legs Syndrome and Periodic Limb Movements in Sleep. Tremor Other Hyperkinet Mov (N Y). 2024;14:21.

  217. Joseph V, Nagalli S. Periodic Limb Movement Disorder.  StatPearls. Treasure Island (FL): StatPearls Publishing. Copyright © 2023, StatPearls Publishing LLC.; 2023.

  218. Stefani A, Högl B. Diagnostic Criteria, Differential Diagnosis, and Treatment of Minor Motor Activity and Less Well-Known Movement Disorders of Sleep. Curr Treat Options Neurol. 2019;21(1):1.

  219. Chenini S, Rassu AL, Barateau L, Lopez R, Carlander B, Guiraud L, et al. Increased Blood Pressure Dipping in Restless Legs Syndrome With Rotigotine: A Randomized Trial. Mov Disord. 2020;35(12):2164-73.

  220. Toma D, Bertram S, Racovitan D, Seidel M, Doevelaar A, Seibert FS, et al. The impact of treatment of periodic limb movements in sleep on blood pressure in patients with and without sleep apnea. Scientific Reports. 2022;12(1):3613.

  221. Haba-Rubio J, Frauscher B, Marques-Vidal P, Toriel J, Tobback N, Andries D, et al. Prevalence and determinants of rapid eye movement sleep behavior disorder in the general population. Sleep. 2017;41(2).

  222. Trotti LM. REM sleep behaviour disorder in older individuals: epidemiology, pathophysiology and management. Drugs Aging. 2010;27(6):457-70.

  223. Postuma RB, Gagnon JF, Tuineaig M, Bertrand JA, Latreille V, Desjardins C, et al. Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal? Sleep. 2013;36(11):1579-85.

  224. Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, Montplaisir J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology. 2009;72(15):1296-300.

  225. Iranzo A, Molinuevo JL, Santamaría J, Serradell M, Martí MJ, Valldeoriola F, et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol. 2006;5(7):572-7.

  226. Elder GJ, Lazar AS, Alfonso-Miller P, Taylor J-P. Sleep disturbances in Lewy body dementia: A systematic review. International Journal of Geriatric Psychiatry. 2022;37(10).

  227. Antelmi E, Pizza F, Franceschini C, Ferri R, Plazzi G. REM sleep behavior disorder in narcolepsy: A secondary form or an intrinsic feature? Sleep Med Rev. 2020;50:101254.

Föregående sida
REM sleep behavior disorder

Nästa sida
Tillbaka till kapitlets första sida